Unichem Laboratories Ltd.

519.40 +3.00 ▲0.6%

29 February 2024, 04:01:00 PM
Volume: 523

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.unichemlabs.com
Market Cap 3,656.87 Cr.
Enterprise Value(EV) 3,868.29 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 2.07 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 251.02 Trailing Twelve Months Ending 2023-12
Industry PE 41.63 Trailing Twelve Months Ending 2023-12
Book Value / Share 353.95 Trailing Twelve Months Ending 2023-12
Price to Book Value 1.47 Calculated using Price: 519.40
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 7.04 Cr. 70,405,751 Shares
FaceValue 2
About Unichem Laboratories Ltd.
Unichem Laboratories, incorporated in 1962, is engaged in manufacturing formulations, pharmaceuticals and active pharmaceutical ingredients (APIs). The company was promoted by the late Amrut Mody, a pioneer in the Indian pharmaceuticals business.

Unichem Laboratories Ltd. Delivery

Delivered Qty
Traded Qty

Unichem Laboratories Ltd. Performance

1 Day
+0.58%
1 Week
-4.15%
1 Month
+14.58%
3 Month
+23.84%
6 Month
+25.19%
1 Year
+75.09%
2 Year
+105.34%
5 Year
+169.33%
10 Year
+138.20%

Unichem Laboratories Ltd. Fundamental Ratios

9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 8.95 11.88 -7.02 -7.11 -0.97 -2.34 1.35 1.28 -8.04
Return on Capital Employed (%) 9.29 14.93 -7.36 -6.1 -1.85 -1.46 2.11 1 -5.6
Return on Assets (%) 6.55 8.79 -5 -5.65 -0.81 -1.92 1.1 1.03 -6.22

Unichem Laboratories Ltd. Balance Sheet

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 868 954 1,064 2,680 2,620 2,531 2,557 2,618 2,435 2,408
Non Curr. Liab. 74 76 64 46 10 44 49 144 108 103
Curr. Liab. 212 275 393 464 503 567 506 552 640 554
Minority Int.
Equity & Liab. 1,153 1,305 1,521 3,190 3,133 3,142 3,112 3,314 3,183 3,065
Non Curr. Assets 589 673 772 854 1,094 1,455 1,734 1,666 1,591 1,529
Curr. Assets 564 632 748 2,336 2,038 1,686 1,377 1,645 1,588 1,536
Misc. Exp. not W/O
Total Assets 1,153 1,305 1,521 3,190 3,133 3,142 3,112 3,314 3,183 3,065

Unichem Laboratories Ltd. Profit and Loss

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 1,202 1,333 698 815 1,180 1,104 1,235 1,270 1,343 1,675
Other Income 21 19 6 61 98 91 50 48 39 31
Total Income 1,223 1,352 703 875 1,278 1,195 1,285 1,317 1,382 1,706
Total Expenditure -1,101 -1,169 -739 -946 -1,264 -1,155 -1,144 -1,197 -1,389 -1,584
PBIDT 122 183 -36 -71 15 40 141 120 -7 122
Interest -3 -3 -3 -8 -8 -8 -5 -6 -17 -24
Depreciation -41 -39 -44 -51 -67 -82 -84 -91 -113 -116
Taxation -2 -29 12 -3 34 -12 -17 11 -26 -2
Exceptional Items -4 -39 34
PAT 75 108 -71 -133 -26 -60 34 33 -202 15
Minority Interest
Share Associate 0
Other Related Items
Consolidated Net Profit 75 108 109 2,545 -24 -60 34 33 -202 15
Adjusted EPS 8 12 12 362 -3 -9 5 5 -29 2

Unichem Laboratories Ltd. Cash Flow

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 87 78 112 68 -112 -328 20 33 -260 -85
Cash Fr. Inv. 36 -52 -85 -128 1,648 -286 -36 -74 102 203
Cash Fr. Finan. -95 -51 -33 59 -881 -2 -62 -121 191 -81
Net Change 28 -25 -7 0 655 -616 -78 -162 34 36
Cash & Cash Eqvt 52 27 20 11 666 197 232 77 109 184

Unichem Laboratories Ltd. Shareholding Pattern

9 Qtrs 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%)
Promoter 50.93 50.93 50.93 50.93 50.93 50.93 50.93 70.21 70.22
Public 49.07 49.07 49.07 49.07 49.07 49.07 49.07 29.79 29.78
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Unichem Laboratories Ltd. Announcements

Thu, 22 Feb 2024
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication - Postal Ballot Notice
Wed, 21 Feb 2024
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Intimation of Postal Ballot Notice
Tue, 13 Feb 2024
The United States Food And Drug Administration (USFDA) Conducted Inspection At The Company'S Ghaziabad (Uttar Pradesh) Formulation Facility From February 7 2024 To February 13 2024.
The United States Food and Drug Administration (USFDA) conducted inspection at the Companys Ghaziabad (Uttar Pradesh) formulation facility from February 7 2024 to February 13 2024

Unichem Laboratories Ltd. Technical Scans

Thu, 29 Feb 2024
Opening at Low Opening at Low
Making Lower Lows for 3 days Making Lower Lows for 3 days
Close Within 52 Week High Zone Close Within 52 Week High Zone
Close Below Last Week Low Close Below Last Week Low
Close Above Last Month High Close Above Last Month High

Unichem Laboratories Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 378,183.18 1,577.95 +0.3%
Cipla Ltd. 119,792.84 1,480.35 +0.2%
Dr. Reddy's Laboratories Ltd. 107,100.71 6,424.25 -0.1%
Zydus Lifesciences Ltd. 95,405.30 941.90 +1.0%
Divi's Laboratories Ltd. 92,624.64 3,489.10 -0.7%
Torrent Pharmaceuticals Ltd. 90,256.63 2,666.80 +2.2%
Apollo Hospitals Enterprise Ltd. 87,793.47 6,105.90 -3.9%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 42.46 1,577.95 +0.3%
Cipla Ltd. Consolidated 2023-12 32.31 1,480.35 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 20.49 6,424.25 -0.1%
Zydus Lifesciences Ltd. Consolidated 2023-12 32.08 941.90 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-12 66.98 3,489.10 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 60.41 2,666.80 +2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 111.23 6,105.90 -3.9%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 6.06 1,577.95 +0.3%
Cipla Ltd. Consolidated 2023-12 4.63 1,480.35 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.99 6,424.25 -0.1%
Zydus Lifesciences Ltd. Consolidated 2023-12 4.91 941.90 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-12 7.11 3,489.10 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 12.62 2,666.80 +2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 13.00 6,105.90 -3.9%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,577.95 +0.3%
Cipla Ltd. Consolidated 2023-03 0.02 1,480.35 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,424.25 -0.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 941.90 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,489.10 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,666.80 +2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,105.90 -3.9%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,577.95 +0.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,480.35 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,424.25 -0.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 941.90 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,489.10 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,666.80 +2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,105.90 -3.9%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,577.95 +0.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,480.35 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,424.25 -0.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 941.90 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,489.10 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,666.80 +2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,105.90 -3.9%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,577.95 +0.3%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,480.35 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,424.25 -0.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 941.90 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,489.10 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,666.80 +2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,105.90 -3.9%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,577.95 +0.3%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,480.35 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,424.25 -0.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 941.90 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,489.10 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,666.80 +2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,105.90 -3.9%

Unichem Laboratories Ltd. FAQ's

What is Unichem Lab share price?

Can I buy Unichem Lab shares now?

What is the Market Cap of Unichem Lab?

What are the key metrics to analyse Unichem Lab?

What is the 52 Week High and Low of Unichem Lab?

What is the trend of Unichem Lab share price?